My Member Center

Pharmaceutical Access

image alt text
Photo: Justin Veneman, St. Jude Children’s Research Hospital; Memphis, Tennessee

Understanding Pharmaceuticals

Latest Update

  • Congress is currently reviewing competing drug packages: H.R. 3, the Lower Drug Costs Now Act of 2019 and S. 2543, the Prescription Drug Pricing Reduction Act.

  • The Centers for Medicare & Medicaid Services announced a plan to collect 340B drug acquisition costs from hospitals. 



Featured Resource

Resource Image
Article
How Children's Hospitals are Confronting the Opioid Crisis October 18, 2018

Explore stories of how hospitals are creating new programs and best practices to address opioid use.

Resources

Narrow By:

Analysis or Summary
Summary of Recent 340B Regulatory Developments
February 13, 2020

CHA developed a summary of federal regulatory activities related to the 340B program.

Analysis or Summary
MedPAC Examines 340B Drug Discount Program
January 23, 2020

On Jan. 17, 2020, MedPAC discussed whether the 340B program creates incentives for participating hospitals to use more expensive drugs.

Analysis or Summary
2019 State Child Health Policy Trends
January 10, 2020

This CHA report provides an analysis of state child health policy trends identified through calls with GRs and state children's hospital associations.

Analysis or Summary
CY 2020 Medicare OPPS Final Rule
December 31, 2019

CMS released the CY 2020 Medicare Hospital Outpatient Prospective Payment System final rule.

Analysis or Summary
Implications for Children of ACA Constitutionality Case
December 20, 2019

The Fifth Circuit Court of Appeals ruled that the ACA's individual mandate and the entire law is unconstitutional.

Analysis or Summary
Cures 2.0: CHA Letter Responding to RFI
December 18, 2019

CHA submitted comments to the request for information on a Cures 2.0 package.

Analysis or Summary
CMS announces plan to collect 340B drug acquisition price information
December 2, 2019

CMS announced a proposed hospital survey for specified covered outpatient drugs.

Letter or Testimony
CHA endorses MEDS Act
November 6, 2019

CHA joined over 50 allied health partners in supporting S. 2723, the MEDS Act.

Letter or Testimony
CHA Endorses House Bill to Boost Support for Pediatric Researchers
October 24, 2019

CHA endorses bill to increase support for pediatric researchers.

Analysis or Summary
CHA Comments on Proposed Rule to Roll Back Nondiscrimination Protections
August 13, 2019

HHS released a proposed rule to roll back key aspects of a former rule that implemented the ACA's non-discrimination provisions, known as Section 1557.

Letter or Testimony
CHA Supports VACCINES Act of 2019
June 13, 2019

Analysis or Summary
Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule
May 23, 2019

On May 23, CMS published a final rule in the Federal Register to modernize Part D and Medicare Advantage.

Article
Minimizing Opioid Misuse in Adults and Treating Pain in Children
April 26, 2019

This pain management advocate shares his thoughts on opioids and pediatric patients.

Analysis or Summary
Summary of Final Annual Guidance for Private Insurance Plans
April 25, 2019

This CHA summary of the 2020 Final Notice of Benefits and Payment Parameters highlights several policies that could impact children’s commercial health coverage.

Article
Rethinking Children's Pain Management in the Opioid Crisis
April 16, 2019

Current prescribing strategies may look like fewer opioids paired with other, non-opioid pain management tactics.

Article
5 Considerations for Children's Hospitals' Pain Management Practices
April 16, 2019

One pain expert says there are things providers should consider when prescribing opioids so children don’t have to endure unnecessary pain.

Article
Balancing Pediatric Patient Care and Effective Pain Management
April 16, 2019

How Seattle Children’s Hospital manages prescribing opioids for postoperative pain.

Article
Defining Opioid Misuse and Abuse
April 16, 2019

A pediatric pain medicine expert discusses striking a balance in prescribing opioids to children.

Letter or Testimony
CHA Endorses Bills to Improve Competition in Generic Drug Market
April 11, 2019

CHA signs letter endorsing bills to increase competition in the generic drug market.

Article
3 Interventions to Reduce Variation in Opioid Prescribing for Pediatric Patients
March 20, 2019

Children’s Hospital Colorado outlines its approach to determining pediatric-specific recommendations for opioid prescribing.

Article
How Pharmacogenomics Can Improve Pediatric Patient Safety
March 20, 2019

Pharmacogenomics is the study of using a patient's genomic makeup to recommend medications, potentially reducing patient harm and improving medication adherence.

Talking Points
How 340B Helps Hospitals
March 7, 2019

The federal 340B program supports children's hospitals in their mission to serve low-income, uninsured and under-insured patients.

Analysis or Summary
Seven Pharmaceutical Executives Testify before Senate Finance
February 27, 2019

Summary of Drug Pricing in America: A Prescription for Change, Part II hearing.

Analysis or Summary
HHS Proposes Revisions to Anti-Kickback Statute Safe Harbor to Eliminate Drug Rebates for PBM’s
February 21, 2019

The Department of Health and Human Services (HHS) published a proposed rule in the Federal Register that would eliminate from safe harbor protection under the Anti-Kickback Statute rebates on prescription drugs.

Announcement or News
CHA Joins Allied Hospitals Partners in Running Pro-340B Ads
February 7, 2019

CHA joined allied DC based hospital associations in promoting the 340B Drug Discount Program by running ads.

Load More Results

Contacts

Newsletters

Policy Update Calls

Members receive the latest updates and suggest ways to best influence policy issues that impact children's health and children's hospitals in a weekly conference call.

Champions for Children's Health

©Children's Hospital Association